Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Hedge Funds Care gives lifetime achievement award to Paul Roth

Monday, March 11, 2013

amb
Paul Roth
Bailey McCann, Opalesque New York:

The 15th Annual New York Open Your Heart to the Children Benefit for Hedge Funds Care took place on Thursday at Cipriani 42nd Street, in Manhattan. The annual benefit is organized by Hedge Funds Care, an international non-profit organization that raises funds from the hedge fund industry to help prevent child abuse and treat its victims in cases where prevention proves impossible. The event raised nearly $2 million from fundraising, event ticket sales, and a silent auction held during the benefit.

"We had several good weeks of fundraising leading up to the event, people have been generous," said Dean Backer, President of Hedge Funds Care, and Global Head of Sales and Capital Introduction in the Global Securities Services business at Goldman Sachs, speaking with Opalesque.

The organization also gave a life time achievement award to Paul Roth, Founding Partner of Schulte Roth & Zabel LLP, for his commitment to philanthropy and is work with the hedge funds industry. The proceeds from the event will fund programs in New York, New Jersey, and Connecticut.

The organization itself is also expanding, and now has chapters in 11 cities, primarily around financial centers. "We most recently opened in Dublin," said Dr. Kathryn Conroy, Executive Director and CEO, Hedge Funds Care. "We are starting small there but are working to have the same level of support that we see here in New York."

Conroy is ta......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for